Study on the clinical effecy and mechanism of KaiyuTongzhi method in treating metabolic syndrome

Guang'anmen Hosptial0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•(1) Age 18-60 years old, gender is not limited;
•(2) Central obesity: waist circumference male = 90cm, female = 85cm;
•(3) Hyperglycemia: fasting blood glucose = 6.1 mmol/L or 2 h after sugar load blood glucose = 7.8 mmol/L and/or those who have been diagnosed with diabetes and treated;
•(4) Hypertension: blood pressure = 130/85 mmHg (1 mmHg = 0.133 kPa) and /or has been confirmed as hypertension and treated;
•(5) Fasting triglycerides (TG) = 1.70 mmol/L;
•(6) Fasting HDL cholesterol (HDL-C) < 1.04 mmol/L;
•(7) The TCM syndrome classification are hepatic depression stagnation and syndrome of intermingled phlegm and blood stasis.
•(3)(4)(5)(6) is diagnostic with two or more items.

•(1) Patients with serious complications of type 2 diabetes mellitus (such as diabetic nephropathy, diabetic foot, diabetic ketoacidosis, etc.);
•(2) Patients with severe primary diseases such as uncontrolled hypertension, myocardial infarction, coronary atherosclerosis, cerebral infarction, infectious liver disease, kidney failure, glomerulonephritis and so on;
•(3) Patients who are suspicious or have been clearly diagnosed with skin problems, soft tissue injuries, osteoarthropathy, gastrointestinal diseases, blood diseases with bleeding tendencies, etc. that are not suitable for manual treatment;
•(4) Pregnant and lactation patients;
•(5) Those who have a serious gastrointestinal reaction after taking metformin and cannot continue to take the drug;
•(6) Patients with mental illness, cognitive dysfunction, inability to cooperate with doctors;
•(7) Easy to lose visit, such as frequent changes in the working environment;
•(8) Patients who are participating in other clinical trials.

发起方

Guang'anmen Hosptial